Navigation Links
Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
Date:10/21/2009

PRINCETON, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device/pharmaceutical company focusing on advanced wound care, today announced that eleven clinical case series regarding its flagship product, MEDIHONEY®, will be presented at the upcoming October 22-25 Clinical Symposium on Advances in Skin & Wound Care in San Antonio. These presentations include:

"Active Leptospermum Honey and Negative Pressure Wound Therapy for Non-Healing Post-Surgical Wounds"

Edna Acuna, MD

Medical Director, Wound & Hyperbaric Clinic, Methodist Medical Center, Dallas, TX

"Honey under Negative Pressure Wound Therapy: A New Approach to Removing Devitalized Tissue"

Paul A. Ligouri, MD, Kim L. Peters, RN, CWS, Jolene Bowars, RN, and Sandra Senno, MD

Haverhill Rehabilitation Hospital, Haverhill, MA

"Use of Honey Dressings for Infected Left Ventricular Assist Device Wounds"

Genevieve O'Shea, BN, RN, CCRN and Kathleen Lockard, BSN, RN, MBA

Artificial Heart Program, University of Pittsburgh, Pittsburgh, PA

"Evidence Based Practice for Pediatric Wound Care: Utilizing Active Leptospermum Honey as a Primary Dressing for Chronic Wounds"

Charlene Deo, RN, CWOCN

Lucile Packard Childrens Hospital at Stanford, Palo Alto, CA

"Active Leptospermum Honey for Pediatric Wound Care: Moving Evidence into Practice"

Roxana Reyna, RNC, WCC

Driscoll Children's Hospital, Corpus Christi, TX

"The Clinical Benefits of Active Leptospermum Honey: Oncologic Wounds"

Debbie Segovia, RN, MSN, CWOCN
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
2. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
3. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
4. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
7. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
8. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
9. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
10. Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Bodys Own Naturally Occurring Stem Cells
11. Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... SOUTHFIELD, Mich. , Feb. 9 /PRNewswire-FirstCall/ ... TEAM ), a worldwide provider of information technology ... that it has named Guido Roumans as director ... responsible for service delivery, relationship management and ongoing ... customers. ,, Roumans has nearly 20 years of ...
(Date:2/9/2010)... India , Feb. 9 ... a presence in India , Western and ... today announced its alliance with DreamCIS Inc., ... Korea .   ,, DreamCIS has nearly a ... to pharmaceutical companies, bio venture companies, medical device ...
(Date:2/9/2010)... Feb. 9 DATATRAK International, Inc. ... on global eClinical solutions for the clinical trials ... Focus, a CRO Connect Partner, will co-sponsor a ... on eClinical solutions for the clinical trials industry. ... and decipher the challenges, costs and obstacles customarily ...
Breaking Medicine Technology:TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 2SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 3DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 2DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 3DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 4AMERIGROUP Announces Preliminary Third Quarter Results 60054 1AMERIGROUP Announces Preliminary Third Quarter Results 60054 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 3AMERIGROUP Announces Preliminary Third Quarter Results 60054 4AMERIGROUP Announces Preliminary Third Quarter Results 60054 5Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation 5676 1Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation 5676 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 1Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 3Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 4
... with VELCADE, lenalidomide,and dexamethasone , ,KOS, Greece, ... MLNM) today reported on the,presentation of results ... that showed consistently high survival and complete,remission ... diagnosed,multiple myeloma (MM) patients. These data were ...
... with Synagis Decreases Incidence of Recurrent Wheeze ... Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbott and ... published in the July issue of Journal ... reduce recurrent wheezing in premature infants by ...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 2Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 3Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 6Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 7Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 8New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
(Date:2/9/2010)... See Idaho Lose $1.6 Billion from Feds & ... Feb. 9 As the Idaho House approved ... health care law, the long-term effects of the move could ... Idaho Health Freedom Act (House Bill 391) a disastrous and ... see Idaho lose nearly $1.6 billion ...
(Date:2/9/2010)... comprehensive study to date of secondhand smoke exposure among ... Addiction . The study, carried out by researchers ... that exposure to household secondhand smoke among children aged ... wanted to find out if there were ways to ... in private households, and whether those levels were changing ...
(Date:2/9/2010)... 2010)- Consuming two or more soft drinks per week ... two-fold compared with individuals who did not consume soft ... Biomarkers & Prevention , a journal of the American ... pancreatic cancer remains one of the most deadly; only ... years later. , Mark Pereira, Ph.D., senior author on ...
(Date:2/9/2010)... has increased in infants born prematurely in the US, ... Health System (LUHS). These findings were reported at the ... in Chicago. They also were published in the latest ... Gynecology . , Researchers reported that CP is associated ... cord. This inflammation is more common in premature births ...
(Date:2/9/2010)... AcademyHealth today recognized research that improves patient safety ... Research (HSR) Impact Award. The WHO Surgical Safety ... adherence to basic safety standards of care. ... clearly translated into policy and, ultimately, made our ... David Helms, Ph.D. "The WHO Surgical Safety Checklist ...
Breaking Medicine News(10 mins):Health News:Idaho House Moves State Closer to Health Care Disaster 2Health News:Idaho House Moves State Closer to Health Care Disaster 3Health News:Idaho House Moves State Closer to Health Care Disaster 4Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:Soft drinks may increase risk of pancreatic cancer 2Health News:Incidence of cerebral palsy on rise in US 2Health News:2010 HSR Impact Award recognizes surgical safety research 2
... takes snapshots of the small intestine as it moves ... Crohns disease that had gone undiagnosed for up to ... Baptist Medical Center. , Reporting this week at the ... said that of 198 video capsule endoscopies that were ...
... Oct. 16 Starpharma,Holdings Ltd (ASX: SPL, Pink ... with SSL International plc (LSE: SSL), owner of ... under which a commercial licence will be negotiated,sets ... VivaGel(R) coating.,Undisclosed fees are payable to Starpharma under ...
... set but don,t reach exercise goals; American Heart ... Move Countdown to help, DALLAS, Oct. 16 Sixty-nine ... 12 months but only 22 percent,achieved theirs, according to a ... ) The survey showed that exercise goals -- particularly ...
... Fla., Oct. 16 Many people know that you ... are exercising. But it can be used,in other ways, ... of the health of,your cardiovascular system," says Stan Reents, ... A person,s heart rate increases as exercise intensity ...
... 16 Despite a recent law signed by,President ... treatments and procedures is still unavailable to average ... from HealthLat, (http://www.healthlat.com ) to make truly informed ... effectively monitor patient safety.,Lacking incentives, shareholders are reluctant ...
... Delegations of Major Community-Organization CEOs to Meet with,Members ... The senior leadership of,major community-based Hispanic health ... lobby for a congressional override of President,George W. ... improve the State,Children,s Health Insurance Program (SCHIP)., ...
Other Medicine News:Health News:Capsule endoscopy turning up undiagnosed cases of Crohn's disease 2Health News:Starpharma and Durex Sign Co-Development Agreement for VivaGel(R)-Coated Condoms 2Health News:Nine of 10 Women Attempt Exercise Goals After Initial Failure, Survey Shows 2Health News:Nine of 10 Women Attempt Exercise Goals After Initial Failure, Survey Shows 3Health News:Exercise And Health: Use Your Heart Rate As a Guide 2Health News:Innovative Healthcare Experience Reports from HealthLat Make Patients More Informed 2Health News:National Alliance for Hispanic Health Ramps Up Lobbying for SCHIP Veto Override 2
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: